BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28528606)

  • 21. The hair follicle melanocytes in vitiligo in relation to disease duration.
    Anbar TS; Abdel-Raouf H; Awad SS; Ragaie MH; Abdel-Rahman AT
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):934-9. PubMed ID: 19453793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes.
    Qiao Z; Wang X; Xiang L; Zhang C
    Oxid Med Cell Longev; 2016; 2016():3401570. PubMed ID: 28018522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Halo nevi and the Vogt-Koyanagi-Harada syndrome. Manifestations of vitiligo.
    Nordlund JJ; Albert D; Forget B; Lerner AB
    Arch Dermatol; 1980 Jun; 116(6):690-2. PubMed ID: 7377805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vogt-Koyanagi-Harada syndrome].
    Mounach J; Sekkach Y; Baizri H; Qaçif H; Ghafir D
    Presse Med; 2009 Jan; 38(1):161-2. PubMed ID: 19004610
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Culture of melanocytes obtained from normal and vitiligo subjects.
    Im S; Hann SK; Park YK; Kim HI
    Yonsei Med J; 1992 Dec; 33(4):344-50. PubMed ID: 1309014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A rare case of ocular scarrings in a patient with Vogt-Koyanagi-Harada disease].
    Belmokhtar A; Daoudi R
    Pan Afr Med J; 2017; 28():313. PubMed ID: 29721143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo with an inflammatory erythema in Vogt-Koyanagi-Harada disease: demonstration of filamentous masses and amyloid deposits.
    Kumakiri M; Kimura T; Miura Y; Tagawa Y
    J Cutan Pathol; 1982 Aug; 9(4):258-66. PubMed ID: 7119218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review.
    Tham HL; Linder KE; Olivry T
    BMC Vet Res; 2019 Jul; 15(1):251. PubMed ID: 31324191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vogt-Koyanagi-Harada syndrome: Association with alopecia areata.
    Haque WM; Mir MR; Hsu S
    Dermatol Online J; 2009 Dec; 15(12):10. PubMed ID: 20040260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytological analysis of ocular and cutaneous lesions in Vogt-Koyanagi-Harada syndrome].
    Ikui H; Mimura M
    Nippon Ganka Gakkai Zasshi; 1970 Sep; 74(9):1100-6. PubMed ID: 5528713
    [No Abstract]   [Full Text] [Related]  

  • 33. Vogt-Koyanagi-Harada syndrome after cutaneous injury.
    Rathinam SR; Namperumalsamy P; Nozik RA; Cunningham ET
    Ophthalmology; 1999 Mar; 106(3):635-8. PubMed ID: 10080227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vogt-Koyanagi-Harada syndrome: review of clinical features.
    Pan D; Hirose T
    Semin Ophthalmol; 2011; 26(4-5):312-5. PubMed ID: 21958180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of melanocye-keratinocyte co-culture model for controls and vitiligo to assess regulators of pigmentation and melanocytes.
    Kumar R; Parsad D; Kanwar A; Kaul D
    Indian J Dermatol Venereol Leprol; 2012; 78(5):599-604. PubMed ID: 22960816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphology of melanocytes in hair bulbs and eyes of vitiligo mice.
    Boissy RE; Moellmann GE; Lerner AB
    Am J Pathol; 1987 May; 127(2):380-8. PubMed ID: 3578491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitiligo: a sign of systemic disease.
    Huggins RH; Janusz CA; Schwartz RA
    Indian J Dermatol Venereol Leprol; 2006; 72(1):68-71. PubMed ID: 16481722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glabrous lesional stem cells differentiated into functional melanocytes: new hope for repigmentation.
    Kumar R; Parsad D; Rani S; Bhardwaj S; Srivastav N
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1555-60. PubMed ID: 27538731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pigment cell transplantation for treatment of vitiligo: a progress report.
    Löntz W; Olsson MJ; Moellmann G; Lerner AB
    J Am Acad Dermatol; 1994 Apr; 30(4):591-7. PubMed ID: 8157785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.